Jenburkt Pharmaceuticals

Jenburkt Pharmaceuticals, founded in 1985, is a prominent entity within the pharmaceutical and healthcare sectors. Headquartered in Mumbai, India, the company maintains a robust operational footprint with 500-1,000 employees dedicated to advancing patient-focused care. Over the past three decades, the organization has established itself as a reliable provider of high-quality prescription medications and over-the-counter drugs. Their commitment to excellence is reflected in their extensive engagement with over 100,000 medical professionals annually, ensuring that therapeutic solutions are aligned with evolving clinical requirements and patient needs.

The company specializes in diverse therapeutic areas, including pain management and anti-infectives, leveraging state-of-the-art manufacturing facilities to maintain rigorous quality standards. Jenburkt Pharmaceuticals operates with a significant global presence, currently serving markets across 13 countries. Their internal R&D capabilities are central to their business model, driving the development of innovative pharmaceutical formulations that address complex health challenges. By integrating advanced technology into their production processes, they consistently deliver healthcare solutions that improve global health outcomes while adhering to international regulatory benchmarks for safety and efficacy.

Operational efficiency remains a core pillar for the firm, which manages its activities from a single primary location in Mumbai. Meet Jenburkt Pharmaceuticals's team to gain insights into the leadership and organizational structure driving these initiatives. The company is publicly traded on the Bombay Stock Exchange under the ticker BSE: 524731, reflecting its established market position and transparency. With a focus on sustainable growth and therapeutic innovation, Jenburkt Pharmaceuticals continues to expand its influence in the global healthcare landscape, maintaining a strong reputationView more...